HHS' decision "could stagnate research that has the potential to save millions of lives," writes Simon Williams.

Ron Lanton, partner, Lanton Law, explains why evolving federal guidance and new technologies are pushing clinical operations teams to strengthen oversight and safeguard the credibility of clinical ...